Abstract 2939: The effect of cSNX1.3 on MMTV-PyMT tumor growth and metastasis

转移 癌症 医学 癌症研究 肿瘤科 内科学
作者
Delina J. Denogean,Barbara Sands,Joyce A. Schroeder
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:85 (8_Supplement_1): 2939-2939
标识
DOI:10.1158/1538-7445.am2025-2939
摘要

Abstract The Epidermal Growth Factor Receptor (EGFR) belongs to a group of Receptor Tyrosine Kinases (RTKs) that are a part of the HER family. EGFR mediates many processes in the cell including proliferation, migration, and survival however its overexpression is correlated with poor prognosis in several epithelial cancers including Triple Negative Breast Cancer (TNBC). In healthy cells, EGF binds to EGFR dimerizes and undergoes transphosphorylation, and can then be intracellularly imported where it is taken to the early endosome and awaits ubiquitination. This signals readiness to be taken to the lysosome where it undergoes degradation or in some cases, gets recycled. In cancerous cells, however, ubiquitination gets inhibited due to their loss of polarity. This results in failure to signify readiness to be taken to the lysosome which allows EGFR to completely evade degradation and undergo nuclear localization. This process is initiated by the binding of Sorting Nexin 1 (SNX1), a protein responsible for the regulation of trafficking, to EGFR. Considering the interaction between Sorting Nexins and RTKs causes oncogenic activity, it was hypothesized in this lab that a therapeutic that can modify this interaction can alter tumor-specific retrotranslocation. In order to target these interactions, the therapeutic peptide, cSNX1.3, was developed. cSNX1.3 is a cell-penetrating peptide with a Protein Transduction Domain that allows for the delivery of peptides across the cell membrane and into the intracellular domain. cSNX1.3 interacts with EGFR when it’s in the long-lived endosome and binds in competition with SNX1. When cSNX1.3 is bound to EGFR, it is able to inhibit the nuclear localization of the RTK and as a result, inhibit its oncogenic activity. In order to fully evaluate the tumor-regressing abilities of cSNX1.3, we used an immunocompetent model of transgenic Whey Acidic Protein - Transforming Growth Factor alpha (WAP-TGFα) mice, whose mammary gland tumors are EGFR dependent. These mice were treated with cSNX1.3 or the control drug, cPTD4, over the course of 4 weeks. After completion of treatment, it was determined that the tumors of the cPTD4-treated mice continued to grow whereas the tumors of the cSNX1.3-treated mice began to regress. We then decided to construct an additional study using another immunocompetent mouse model that would also demonstrate how cancer metastasis reacted to cSNX1.3 treatment, given that metastasis is typically what makes breast cancer fatal in humans. For these reasons, we decided to use a model of transgenic Mouse Mammary Tumor Virus - Polyoma Middle T (MMTV-PyMT) mice. Conducting an evaluation of cSNX1.3 using this model that closely resembles the function of metastatic breast cancer in humans, will allow us to better understand the future of cSNX1.3 as a breast cancer therapeutic for human applications. Citation Format: Delina J. Denogean, Barbara Sands, Joyce Schroeder. The effect of cSNX1.3 on MMTV-PyMT tumor growth and metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 2939.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
白开水完成签到 ,获得积分10
刚刚
卡卡西发布了新的文献求助10
刚刚
大模型的应助被张艺蓝采纳,获得30
1秒前
liao完成签到 ,获得积分10
2秒前
2秒前
落寞的灵萱完成签到 ,获得积分10
3秒前
淡定访琴完成签到,获得积分10
3秒前
852的应助被zhang采纳,获得10
5秒前
fantasy的应助被隔岸采纳,获得10
5秒前
Komorebi完成签到 ,获得积分10
7秒前
hin发布了新的文献求助10
7秒前
8秒前
8秒前
9秒前
cdercder的应助被suiwuya采纳,获得10
10秒前
单薄的绝施完成签到,获得积分10
10秒前
11秒前
11秒前
今后的应助被朴实夏寒采纳,获得30
12秒前
机智冰凡完成签到,获得积分10
12秒前
祺宴发布了新的文献求助10
12秒前
12秒前
14秒前
14秒前
vamcello发布了新的文献求助10
14秒前
keyantong完成签到,获得积分10
14秒前
王艳完成签到,获得积分10
15秒前
清辉影发布了新的文献求助10
15秒前
shushu完成签到,获得积分10
15秒前
111完成签到 ,获得积分10
16秒前
hin完成签到,获得积分20
17秒前
18秒前
18秒前
linda完成签到 ,获得积分10
19秒前
惊嵐发布了新的文献求助10
19秒前
20秒前
21秒前
钧凯发布了新的文献求助10
21秒前
22秒前
卡卡西完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181498
求助须知:如何正确求助?哪些是违规求助? 9571421
关于积分的说明 21817968
捐赠科研通 7777967
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479552